These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 9469682
1. A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Bieniek SA, Ownby RL, Penalver A, Dominguez RA. Pharmacotherapy; 1998; 18(1):57-62. PubMed ID: 9469682 [Abstract] [Full Text] [Related]
2. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. Currier GW, Chou JC, Feifel D, Bossie CA, Turkoz I, Mahmoud RA, Gharabawi GM. J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079 [Abstract] [Full Text] [Related]
3. Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. Salzman C, Solomon D, Miyawaki E, Glassman R, Rood L, Flowers E, Thayer S. J Clin Psychiatry; 1991 Apr; 52(4):177-80. PubMed ID: 1673123 [Abstract] [Full Text] [Related]
4. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study. Hovens JE, Dries PJ, Melman CT, Wapenaar RJ, Loonen AJ. J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129 [Abstract] [Full Text] [Related]
5. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service. Kohen I, Preval H, Southard R, Francis A. Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319 [Abstract] [Full Text] [Related]
6. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. Lenox RH, Newhouse PA, Creelman WL, Whitaker TM. J Clin Psychiatry; 1992 Feb; 53(2):47-52. PubMed ID: 1541605 [Abstract] [Full Text] [Related]
7. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Battaglia J, Moss S, Rush J, Kang J, Mendoza R, Leedom L, Dubin W, McGlynn C, Goodman L. Am J Emerg Med; 1997 Jul; 15(4):335-40. PubMed ID: 9217519 [Abstract] [Full Text] [Related]
8. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. Currier GW, Simpson GM. J Clin Psychiatry; 2001 Mar; 62(3):153-7. PubMed ID: 11305699 [Abstract] [Full Text] [Related]
9. Intravenous Lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial. Marill KA, Walsh MJ, Nelson BK. Ann Emerg Med; 2000 Oct; 36(4):310-9. PubMed ID: 11020677 [Abstract] [Full Text] [Related]
10. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial. Huang CL, Hwang TJ, Chen YH, Huang GH, Hsieh MH, Chen HH, Hwu HG. J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540 [Abstract] [Full Text] [Related]
11. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes. Honderick T, Williams D, Seaberg D, Wears R. Am J Emerg Med; 2003 Jan; 21(1):39-42. PubMed ID: 12563578 [Abstract] [Full Text] [Related]
12. Use of benzodiazepines to control disruptive behavior in inpatients. Salzman C. J Clin Psychiatry; 1988 Dec; 49 Suppl():13-5. PubMed ID: 3058683 [Abstract] [Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
14. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A. Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506 [Abstract] [Full Text] [Related]
15. Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial. Veser FH, Veser BD, McMullan JT, Zealberg J, Currier GW. J Psychiatr Pract; 2006 Mar; 12(2):103-8. PubMed ID: 16728906 [Abstract] [Full Text] [Related]
16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [Abstract] [Full Text] [Related]
17. Systematic reviews of assessment measures and pharmacologic treatments for agitation. Zeller SL, Rhoades RW. Clin Ther; 2010 Mar; 32(3):403-25. PubMed ID: 20399981 [Abstract] [Full Text] [Related]
18. Efficacy and Safety of Levosulpiride Versus Haloperidol Injection in Patients With Acute Psychosis: A Randomized Double-Blind Study. Lavania S, Praharaj SK, Bains HS, Sinha V, Kumar A. Clin Neuropharmacol; 2016 Mar; 39(4):197-200. PubMed ID: 27223668 [Abstract] [Full Text] [Related]